Persistent Asset Partners »

Lexeo Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $159k 16k 9.93

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Lexeo Therapeutics

Henderson Group
BlackRock
Paradigm Biocapital Advisors
Vestal Point Capital
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Citadel Advisors
venBio Select Advisor
Affinity Asset Advisors
Woodline Partners
State Street Corporation
Millennium Management
OrbiMed Advisors
Point72 Asset Management

View all funds holding Lexeo Therapeutics